Table 3. Predictive capability of hypertrophic cardiomyopathy (HCM) virtual-heart technology.
Sensitivity | Specificity | PPV | NPV | Accuracy | |
---|---|---|---|---|---|
ACCF/AHA risk model | 46.2 | 46.2 | 46.2 | 46.2 | 46.2 |
ESC risk model | 53.9 | 38.5 | 46.7 | 45.5 | 46.2 |
Virtual-heart technology: LGE-T1 | 84.6 | 76.9 | 78.8 | 83.3 | 80.1 |
Virtual-heart technology: LGE only | 69.2 | 76.9 | 75.0 | 71.4 | 73.1 |
ACCF = American College of Cardiology Foundation, AHA = American Heart Association, ESC = European Society of Cardiology, LGE = late gadolinium enhancement.